PTAB Will Review Eli Lilly's Patent For Cancer Drug Alimta
The Patent Trial and Appeal Board on Friday agreed to kick off an America Invents Act review of all claims underlying an Eli Lilly & Co. patent covering the blockbuster cancer...To view the full article, register now.
Already a subscriber? Click here to view full article